CD4 and Parkinson disease: Remarkably, such modifications occurred to the same extent in both drug-naïve patients as well as in patients on dopaminergic substitution treatments (Fig. 3 and Additional file 2: Figure S11), suggesting that modifications of the transcription factors network in CD4+ T cells occurs early in PD.